Amy M. Meyer
Impact in
-
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Biochemistry top 10%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Inflammatory mediators and NSAID effects 6
-
- Peroxisome Proliferator-Activated Receptors 2
- Ubiquitin and proteasome pathways 1
- Co-authors
- Lori D. Dwyer‐Nield (8 shared papers)Alvin M. Malkinson (7 shared papers)Alison K. Bauer (3 shared papers)Lori R. Kisley (3 shared papers)Bradley S. Barrett (2 shared papers)David C. Thompson (2 shared papers)Benjamin L. Barthel (1 shared paper)Mark W. Geraci (4 shared papers)
- Journals
- CHEST Journal (2 papers)Carcinogenesis (2 papers)Molecular Pharmacology (1 paper)Cancer Prevention Research (1 paper)American Journal of Physiology-Lung Cellular and Molecular Physiology (1 paper)
- Partner nations
- United StatesJapanSpain
In The Last Decade
Amy M. Meyer
12 papers receiving 483 citations
Peers
Comparison fields: 5 of 63
- Cancer Research 129
- Biochemistry 53
- Pharmacology 107
- Oncology 99
- Molecular Biology 252
Countries citing papers authored by Amy M. Meyer
This map shows the geographic impact of Amy M. Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy M. Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy M. Meyer more than expected).
Fields of papers citing papers by Amy M. Meyer
This network shows the impact of papers produced by Amy M. Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy M. Meyer. The network helps show where Amy M. Meyer may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy M. Meyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Genetic ablation of inducible nitric oxide synthase decreases mouse lung tumorigenesis. | 2002 | 108 |
| 2 | 2004 | 76 | |
| 3 | 2008 | 68 | |
| 4 | 2004 | 62 | |
| 5 | 2007 | 51 | |
| 6 | Prostaglandin E2 receptor subtype 2 (EP2) null mice are protected against murine lung tumorigenesis. | 2006 | 33 |
| 7 | Serum levels of surfactant protein D are increased in mice with lung tumors. | 2003 | 24 |
| 8 | 2005 | 22 | |
| 9 | 2004 | 20 | |
| 10 | 2000 | 18 | |
| 11 | 2006 | 12 | |
| 12 | [Adenocarcinoma of the urachus]. | 1954 | 1 |
About Amy M. Meyer
Amy M. Meyer is a scholar working on Pharmacology, Molecular Biology, Physiology, Biochemistry and Pulmonary and Respiratory Medicine, having authored 12 papers that have together received 495 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (6 papers), Nitric Oxide and Endothelin Effects (3 papers), Eicosanoids and Hypertension Pharmacology (3 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Respiratory Support and Mechanisms (2 papers), Inhalation and Respiratory Drug Delivery (2 papers), Neonatal Respiratory Health Research (2 papers) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Cancer Research (129 citations), Biochemistry (53 citations), Pharmacology (107 citations), Oncology (99 citations) and Molecular Biology (252 citations). Amy M. Meyer has collaborated with scholars based in United States, Japan and Spain. Frequent co-authors include Lori D. Dwyer‐Nield, Alvin M. Malkinson, Alison K. Bauer, Lori R. Kisley, Bradley S. Barrett, David C. Thompson, Benjamin L. Barthel, Mark W. Geraci, Robert L. Keith and Robert A. Winn. Their work appears in journals such as CHEST Journal, Carcinogenesis, Molecular Pharmacology, Cancer Prevention Research and American Journal of Physiology-Lung Cellular and Molecular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.